Actively Recruiting
Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries
Led by Institute of Liver and Biliary Sciences, India · Updated on 2025-12-31
1000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are examining the time it takes for serum albumin levels to recover after major hepatobiliary and pancreatic surgeries. Albumin, a protein that decreases due to inflammation from surgery, may reflect surgical stress and recovery. The study aims to understand how albumin recovery relates to patient outcomes such as complications and hospital stay length, as current data on this recovery time is limited. This observational study focuses on patients undergoing these major surgeries to better predict recovery and risks after surgery. The study involves patients who have had major hepatobiliary or pancreatic surgeries, including a retrospective arm using data from 2010. No active treatment is administered as this is an observational study. Researchers will monitor albumin levels postoperatively to assess the time to albumin recovery and correlate this with various outcomes such as hospital stay duration, complications, intensive care use, and readmission rates. These measures will be tracked over 30 to 90 days after surgery. Participants will have their albumin levels monitored and clinical outcomes recorded to evaluate recovery from surgical stress. Researchers will use classifications like the Clavien Dindo system and the Comprehensive Complication Index to assess complications, along with ICU stays and readmission rates. The main focus is on how quickly albumin levels return to normal and its impact on hospital stay. The total follow-up period may extend up to 90 days to observe post-surgical recovery and outcomes.
CONDITIONS
Brief Title
Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients undergoing major Hepato pancreatico Biliary surgeries
- Patients who are more than 12 years of age
- Retrospective arm includes data from 2010
You will not qualify if you...
- Patients who refuse or are unable to give consent
- Patients with Nephrotic syndrome, Protein losing enteropathies, Inflammatory bowel Disease, Chronic Liver Disease
- Emergency Surgeries
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Hospital stay, up to 30 days
Participants undergo major hepato pancreato biliary surgeries followed by immediate post-operative care to monitor recovery and serum albumin levels.
Approximately daily visits during hospital stay
Duration - Up to 90 days after surgery
Participants are followed after hospital discharge to monitor longer term outcomes including complications, morbidity, and readmission rates.
Follow-up visits as per standard clinical practice during 90 days
Trial Site Locations
Total: 1 location
1
ILBS
New Delhi, National Capital Territory of Delhi, India, 110070
Actively Recruiting
Research Team
D
Dr Rajagopalan G, DNB
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here